Renal transplantation is the gold standard of renal replacement therapy. It enables complete rehabilitation, free from dietary and fluid restriction, restoring all the important excretory and metabolic functions of the kidney.
Success rates for carefully selected patients are high. Patients with grafts that fail can be successfully switched to dialysis.
- renal replacement therapy (RRT) is a treatment option in people with CKD
whose condition progresses to kidney failure
- RRT essentially comprises either transplantation or dialysis (artificially removing waste products and excess water from the blood)
- transplantation can be from living or deceased donors, and for some people it may involve the transplantation of more than one organ simultaneously (for example, combined pancreas and kidney transplantation for people with type I diabetes mellitus). In some cases, transplantation may be pre-emptive, occurring before dialysis would be needed
According to the 19th annual report by the UK Renal Registry (2016), on 31 December 2015 there were 61,256 adults in the UK receiving RRT
- of these, 53.1% had received a transplant, 41.0% were receiving haemodialysis (21.2% in satellite units, 17.8% in hospitals, 2.0% at home), 2.5% were receiving continuous ambulatory peritoneal dialysis and 3.4% were receiving automated peritoneal dialysis
- in addition, 769 children and young people under the age of 16 years were
- most had received a transplant (41% live, 34% deceased), with 13% on haemodialysis and 12% on peritoneal dialysis